Ongoing Securities Investigation into Anika Therapeutics, Inc. (ANIK) - Contact Levi & Korsinsky

Acceswire
2025.08.10 15:30
portai
I'm PortAI, I can summarize articles.

Levi & Korsinsky has initiated an investigation into Anika Therapeutics, Inc. for potential violations of federal securities laws following the company's announcement of clinical trial results for Hyalofast. Despite showing improvements in patient outcomes, the trial did not meet its primary endpoints, leading to a 27% drop in Anika's stock price on July 30, 2025. The investigation aims to gather more information regarding these developments.